Nephrology

Intradialysis hypotension (IDH) commonly complicates haemodialysis treatment, and could be associated with dysfunction…

Diabetic kidney disease (DKD) has been an immense burden on the healthcare system, and is the leading cause of end stage kidney disease…

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are the mainstay of therapy for…

Acquired Epidermodysplasia Verruciformis is a rare entity associated with immunodeficiency, such as kidney transplant patients…

Despite recent developments in renal medicine, mortality rates remain high in patients receiving long-term haemodialysis (HD) due to…

Chronic kidney disease-associated pruritus (CKD-aP) occurs in over two-thirds of patients undergoing haemodialysis. The aetiology of CKD-aP may be multifactorial, involving immune system and opioid dysregulation, peripheral neuropathy, and toxin deposition. CKD-aP can be extremely bothersome for some patients, affecting health-related quality of life and sleep, as well as increasing the likelihood of hospitalisation, infections, and death.

Over the past few decades, there have been important advances in cancer therapeutics, including a shift from traditional cytotoxic…

AAV is a rare and severe multisystem disease affecting the small arteries.1,2 The condition is characterised by systemic inflammation across multiple body sites including the lungs, joints, kidneys, nerves, ears, and nose.1,2 Glucocorticoids and immunosuppressants form the cornerstone of current treatment approaches.